Plain-English translation of NCT06710548 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is testing whether a brief, online coaching program called REVITALIZE can help reduce fatigue — one of the most challenging side effects — for people with advanced ovarian cancer who are taking PARP inhibitors as maintenance therapy. Some participants will receive eight weekly one-on-one coaching sessions plus two follow-up sessions via video call, while others will receive educational materials about cancer survivorship and managing fatigue. The study will follow everyone for about 7 months to see which approach helps people feel less tired and function better in their daily lives.
Fatigue is one of the most common and disruptive side effects for people taking PARP inhibitors, but there are few proven ways to help manage it. This study exists to test whether personalized, acceptance-based coaching — delivered conveniently through video calls from home — can make a real difference in people's energy levels and quality of life.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to either the coaching program or the educational materials group. You'll fill out questionnaires at the start and at several checkpoints (at 8, 13, 20, and 28 weeks). You'll also use a wireless pill bottle that tracks when you take your medication. If you're in the coaching group, you'll have eight weekly one-on-one video sessions with a coach (via Zoom) plus two additional sessions to reinforce what you've learned. If you're in the educational materials group, you'll receive information about cancer survivorship and fatigue management to read on your own. The entire study lasts about 7 months.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States